NADPH oxidase-derived ROS trigger important processes underlying vascular injury including intracellular Ca2+ ion accumulation, reduced NO bioavailability, MAPK activation, endothelial dysfunction, and loss of the anticontractile effect of PVAT. Here, FMO5 is linked to endothelial dysfunction.